An interesting study revealed that (40 nM) allicin inhibited the expression of NRF2 in cervical cancer SiHa cells, thus illustrating its potential therapeutic advantages in cervical cancer treatment [49]. The gene discussed is NFE2L2; the disease is cervical cancer.